跳至主要内容
临床试验/NCT07121543
NCT07121543招募中不适用

Understanding the Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy

University of California, San Diego1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年8月4日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
1
主要终点
Tissue factor expression in tumors

研究概览

简要总结

The goal of this observational study is to learn more about the biology of cervical cancer in women who receive radiation therapy for this condition. The main question it aims to answer is:

Does radiation therapy alter the expression of tissue factor and other molecules in cervical cancer over time?

Participants already scheduled for radiation therapy for cervical cancer as part of their regular medical care will provide blood and biopsies of cervical cancer or of the upper portion of the vagina before, during, and on the last day of radiation therapy.

详细描述

The standard of care treatment for locally advanced cervical cancer is a combination of chemotherapy with cisplatin and radiotherapy. Although patients have improved outcomes with chemo-radiotherapy, tumor recurrence can occur. In addition, combining chemotherapy with radiotherapy increases treatment-related side effects. While breakthroughs in radiotherapy and immunotherapy have resulted in targeted cancer care, chemotherapy given with radiotherapy is a non-targeted approach. Better strategies to treat cervical cancer are needed.

In this study, the investigators will use tissue and blood from patients with cervical cancer to perform translational research. This is necessary to discover molecular pathways that could be targeted in the future with novel agents, such as radiotherapy and immunotherapy, for the treatment of women with cervical cancer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age 18 years or older
  • Pathological diagnosis of cervical cancer
  • Scheduled to receive brachytherapy for cervical cancer

排除标准

  • Pregnancy or lactation
  • Inability to provide a tissue sample

结局指标

主要结局

Tissue factor expression in tumors

时间窗: 8 weeks

Determine the temporal changes of tissue factor expression in the irradiated tumor immune microenvironment.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jyoti Mayadev, MD

Professor, Radiation Medicine and Applied Sciences

University of California, San Diego

研究点 (1)

Loading locations...

相似试验